Recent and ongoing research into metastatic osteosarcoma treatments
MA Harris, CJ Hawkins - International Journal of Molecular Sciences, 2022 - mdpi.com
The survival rate for metastatic osteosarcoma has not improved for several decades, since
the introduction and refinement of chemotherapy as a treatment in addition to surgery. Over …
the introduction and refinement of chemotherapy as a treatment in addition to surgery. Over …
Self-assembled lipid–prodrug nanoparticles
Nanomedicines suffer from poor drug loading and uncontrolled 'burst release'after
administration. Combining prodrug strategies with nanostructured carriers can help to …
administration. Combining prodrug strategies with nanostructured carriers can help to …
Bone marrow mesenchymal stem cells-derived extracellular vesicles promote proliferation, invasion and migration of osteosarcoma cells via the lncRNA MALAT1/miR …
F Li, X Chen, C Shang, Q Ying, X Zhou… - OncoTargets and …, 2021 - Taylor & Francis
Introduction Osteosarcoma is a malignant primary bone tumor. Bone marrow-derived
mesenchymal stem cells-derived extracellular vesicles (BMSC-EVs) bear repair function for …
mesenchymal stem cells-derived extracellular vesicles (BMSC-EVs) bear repair function for …
Nanotechnology for the treatment of paediatric diseases: A review
MS Marques, LA Lima, F Poletto, RV Contri… - Journal of Drug Delivery …, 2022 - Elsevier
In recent years, health authorities have encouraged the development of paediatric
formulations. New technologies have been proposed for the development of paediatric …
formulations. New technologies have been proposed for the development of paediatric …
State of the art in pediatric nanomedicines
S Abedin, OA Adeleke - Drug Delivery and Translational Research, 2024 - Springer
In recent years, the continuous development of innovative nanopharmaceuticals is
expanding their biomedical and clinical applications. Nanomedicines are being …
expanding their biomedical and clinical applications. Nanomedicines are being …
Gemcitabine-Vitamin E Prodrug-Loaded Micelles for Pancreatic Cancer Therapy
Pancreatic cancer (PC) is an aggressive cancer subtype presenting unmet clinical
challenges. Conventional chemotherapy, which includes antimetabolite gemcitabine (GEM) …
challenges. Conventional chemotherapy, which includes antimetabolite gemcitabine (GEM) …
ARHGAP44 expression is associated with the metastasis of osteosarcoma and is a promising prognostic biomarker
S Hu, W Wang - Journal of Orthopaedic Research®, 2023 - Wiley Online Library
Osteosarcoma (OS) is the most domain primary malignant bone tumor. Treatment
resistances and metastases result in a decreasing 5‐year overall survival rate of OS …
resistances and metastases result in a decreasing 5‐year overall survival rate of OS …